Promising new treatment strategy for men with drug-resistant prostate cancer 12 Jan 2021 A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not respond to existing treatments, or develops resistance to them, researchers report. Find out more Show/Hide
Prostate cancer drug targeting Achilles heel approved in Europe 06 Nov 2020 The Institute of Cancer Research, London, has strongly welcomed the approval by the European Commission of the targeted drug olaparib for men with advanced prostate cancers with genetic alterations in BRCA1 or BRCA2. Find out more Show/Hide
New drug targeting DNA repair shows promise in range of advanced cancers 28 Sep 2020 A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors. Find out more Show/Hide
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers 21 Sep 2020